Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: LSD Therapy for Persons Suffering From Major Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LSD-based therapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LSD (lysergic acid diethylamide)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED